| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.33 | 9e-08 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |